IL127550A - Methods and preparations for treating and repairing defects or wounds in cartilage or bone using a functional barrier - Google Patents

Methods and preparations for treating and repairing defects or wounds in cartilage or bone using a functional barrier

Info

Publication number: IL127550A
Authority: IL; Israel
Prior art keywords: matrix; cartilage; bone; defect; factor
Prior art date: 1996-06-28

Application number

IL12755097A

Other languages

English (en)

Hebrew (he)

Other versions

IL127550A0 (en

Original Assignee

Shaw Robert F

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-28

Filing date

1997-06-24

Publication date

2004-06-01

1997-06-24 Application filed by Shaw Robert F filed Critical Shaw Robert F

1999-10-28 Publication of IL127550A0 publication Critical patent/IL127550A0/xx

2004-06-01 Publication of IL127550A publication Critical patent/IL127550A/en

Links

230000007547 defect Effects 0.000 title claims abstract description 249
210000000845 cartilage Anatomy 0.000 title claims abstract description 183
230000008439 repair process Effects 0.000 title claims abstract description 167
210000000988 bone and bone Anatomy 0.000 title claims abstract description 124
238000000034 method Methods 0.000 title claims abstract description 92
239000000203 mixture Substances 0.000 title claims abstract description 92
238000011282 treatment Methods 0.000 title claims abstract description 29
230000003902 lesion Effects 0.000 title claims description 24
230000004888 barrier function Effects 0.000 title abstract description 14
239000011159 matrix material Substances 0.000 claims abstract description 228
239000003795 chemical substances by application Substances 0.000 claims abstract description 79
230000001131 transforming effect Effects 0.000 claims abstract description 72
230000035755 proliferation Effects 0.000 claims abstract description 56
239000004037 angiogenesis inhibitor Substances 0.000 claims abstract description 39
230000003399 chemotactic effect Effects 0.000 claims abstract description 38
238000011049 filling Methods 0.000 claims abstract description 25
230000002188 osteogenic effect Effects 0.000 claims abstract description 25
241001465754 Metazoa Species 0.000 claims abstract description 21
210000002808 connective tissue Anatomy 0.000 claims abstract description 21
210000004204 blood vessel Anatomy 0.000 claims abstract description 19
239000002870 angiogenesis inducing agent Substances 0.000 claims abstract description 17
230000000740 bleeding effect Effects 0.000 claims abstract description 10
230000001052 transient effect Effects 0.000 claims abstract description 6
210000004027 cell Anatomy 0.000 claims description 115
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 58
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 57
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 57
108010067787 Proteoglycans Proteins 0.000 claims description 32
102000016611 Proteoglycans Human genes 0.000 claims description 32
102000008186 Collagen Human genes 0.000 claims description 27
108010035532 Collagen Proteins 0.000 claims description 27
108010073385 Fibrin Proteins 0.000 claims description 27
102000009123 Fibrin Human genes 0.000 claims description 27
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 27
229950003499 fibrin Drugs 0.000 claims description 27
210000001612 chondrocyte Anatomy 0.000 claims description 26
229920001436 collagen Polymers 0.000 claims description 26
230000015572 biosynthetic process Effects 0.000 claims description 21
239000000463 material Substances 0.000 claims description 19
239000002502 liposome Substances 0.000 claims description 18
239000012528 membrane Substances 0.000 claims description 17
210000004379 membrane Anatomy 0.000 claims description 17
230000004069 differentiation Effects 0.000 claims description 11
FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical group OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 claims description 11
229960005314 suramin Drugs 0.000 claims description 10
108010010803 Gelatin Proteins 0.000 claims description 9
239000008273 gelatin Substances 0.000 claims description 9
229920000159 gelatin Polymers 0.000 claims description 9
235000019322 gelatine Nutrition 0.000 claims description 9
235000011852 gelatine desserts Nutrition 0.000 claims description 9
230000011164 ossification Effects 0.000 claims description 8
230000001737 promoting effect Effects 0.000 claims description 8
238000013268 sustained release Methods 0.000 claims description 8
239000012730 sustained-release form Substances 0.000 claims description 8
230000002491 angiogenic effect Effects 0.000 claims description 7
230000009772 tissue formation Effects 0.000 claims description 7
229920000936 Agarose Polymers 0.000 claims description 6
210000002449 bone cell Anatomy 0.000 claims description 6
239000000835 fiber Substances 0.000 claims description 6
101710106625 Chondroitinase-AC Proteins 0.000 claims description 5
230000002308 calcification Effects 0.000 claims description 5
210000004349 growth plate Anatomy 0.000 claims description 5
230000008929 regeneration Effects 0.000 claims description 5
238000011069 regeneration method Methods 0.000 claims description 5
229920013641 bioerodible polymer Polymers 0.000 claims description 4
150000001720 carbohydrates Chemical class 0.000 claims description 4
230000002265 prevention Effects 0.000 claims description 4
239000000839 emulsion Substances 0.000 claims description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
108010000499 Thromboplastin Proteins 0.000 claims description 2
102000002262 Thromboplastin Human genes 0.000 claims description 2
239000011575 calcium Substances 0.000 claims description 2
229910052791 calcium Inorganic materials 0.000 claims description 2
239000008174 sterile solution Substances 0.000 claims description 2
150000003839 salts Chemical class 0.000 claims 1
210000001519 tissue Anatomy 0.000 abstract description 39
239000011148 porous material Substances 0.000 abstract description 7
230000017423 tissue regeneration Effects 0.000 abstract description 4
230000008468 bone growth Effects 0.000 abstract description 2
230000022159 cartilage development Effects 0.000 abstract description 2
230000000149 penetrating effect Effects 0.000 abstract 1
239000000243 solution Substances 0.000 description 75
108010049003 Fibrinogen Proteins 0.000 description 31
102000008946 Fibrinogen Human genes 0.000 description 31
229940012952 fibrinogen Drugs 0.000 description 31
102000004190 Enzymes Human genes 0.000 description 27
108090000790 Enzymes Proteins 0.000 description 27
229940088598 enzyme Drugs 0.000 description 27
230000000694 effects Effects 0.000 description 25
239000003102 growth factor Substances 0.000 description 24
150000001875 compounds Chemical class 0.000 description 23
108090000765 processed proteins & peptides Proteins 0.000 description 23
210000001188 articular cartilage Anatomy 0.000 description 21
108090000190 Thrombin Proteins 0.000 description 20
229960004072 thrombin Drugs 0.000 description 20
102000004196 processed proteins & peptides Human genes 0.000 description 16
102000004169 proteins and genes Human genes 0.000 description 16
108090000623 proteins and genes Proteins 0.000 description 16
238000003556 assay Methods 0.000 description 12
238000002474 experimental method Methods 0.000 description 12
230000012010 growth Effects 0.000 description 12
230000003239 periodontal effect Effects 0.000 description 11
101150021185 FGF gene Proteins 0.000 description 10
241000283973 Oryctolagus cuniculus Species 0.000 description 10
244000309715 mini pig Species 0.000 description 10
230000002297 mitogenic effect Effects 0.000 description 10
201000008482 osteoarthritis Diseases 0.000 description 10
239000000126 substance Substances 0.000 description 10
230000009466 transformation Effects 0.000 description 10
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 9
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 9
238000006116 polymerization reaction Methods 0.000 description 9
229920001184 polypeptide Polymers 0.000 description 9
230000004936 stimulating effect Effects 0.000 description 9
108090000819 Chondroitin-sulfate-ABC endolyases Proteins 0.000 description 8
102000037716 Chondroitin-sulfate-ABC endolyases Human genes 0.000 description 8
208000032843 Hemorrhage Diseases 0.000 description 8
208000034158 bleeding Diseases 0.000 description 8
231100000319 bleeding Toxicity 0.000 description 8
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 7
102100037852 Insulin-like growth factor I Human genes 0.000 description 7
229920002684 Sepharose Polymers 0.000 description 7
230000001772 anti-angiogenic effect Effects 0.000 description 7
239000012062 aqueous buffer Substances 0.000 description 7
230000006378 damage Effects 0.000 description 7
239000003112 inhibitor Substances 0.000 description 7
208000014674 injury Diseases 0.000 description 7
210000000629 knee joint Anatomy 0.000 description 7
230000002062 proliferating effect Effects 0.000 description 7
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 6
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 6
206010061762 Chondropathy Diseases 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
239000008280 blood Substances 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
230000015556 catabolic process Effects 0.000 description 6
230000004663 cell proliferation Effects 0.000 description 6
238000006731 degradation reaction Methods 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
210000000963 osteoblast Anatomy 0.000 description 6
210000005065 subchondral bone plate Anatomy 0.000 description 6
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 6
208000010392 Bone Fractures Diseases 0.000 description 5
241000906034 Orthops Species 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
229910052588 hydroxylapatite Inorganic materials 0.000 description 5
230000001939 inductive effect Effects 0.000 description 5
230000005012 migration Effects 0.000 description 5
238000013508 migration Methods 0.000 description 5
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 5
230000000379 polymerizing effect Effects 0.000 description 5
239000007787 solid Substances 0.000 description 5
230000008733 trauma Effects 0.000 description 5
230000002792 vascular Effects 0.000 description 5
102400001368 Epidermal growth factor Human genes 0.000 description 4
101800003838 Epidermal growth factor Proteins 0.000 description 4
102000016359 Fibronectins Human genes 0.000 description 4
108010067306 Fibronectins Proteins 0.000 description 4
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
102000055008 Matrilin Proteins Human genes 0.000 description 4
108010072582 Matrilin Proteins Proteins 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
230000004071 biological effect Effects 0.000 description 4
239000001506 calcium phosphate Substances 0.000 description 4
230000021164 cell adhesion Effects 0.000 description 4
230000012292 cell migration Effects 0.000 description 4
230000003111 delayed effect Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
229940116977 epidermal growth factor Drugs 0.000 description 4
210000000981 epithelium Anatomy 0.000 description 4
230000035876 healing Effects 0.000 description 4
210000004276 hyalin Anatomy 0.000 description 4
210000003035 hyaline cartilage Anatomy 0.000 description 4
230000006698 induction Effects 0.000 description 4
210000003127 knee Anatomy 0.000 description 4
210000004409 osteocyte Anatomy 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
229920001817 Agar Polymers 0.000 description 3
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 3
102000000503 Collagen Type II Human genes 0.000 description 3
108010041390 Collagen Type II Proteins 0.000 description 3
206010017076 Fracture Diseases 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
229920002971 Heparan sulfate Polymers 0.000 description 3
239000004365 Protease Substances 0.000 description 3
108090000631 Trypsin Proteins 0.000 description 3
102000004142 Trypsin Human genes 0.000 description 3
108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
239000008272 agar Substances 0.000 description 3
108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 3
230000010478 bone regeneration Effects 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
230000032823 cell division Effects 0.000 description 3
230000035605 chemotaxis Effects 0.000 description 3
239000007857 degradation product Substances 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
-1 i.e. Substances 0.000 description 3
238000000099 in vitro assay Methods 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
210000003041 ligament Anatomy 0.000 description 3
230000033001 locomotion Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000003204 osmotic effect Effects 0.000 description 3
230000036407 pain Effects 0.000 description 3
208000028169 periodontal disease Diseases 0.000 description 3
230000008569 process Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
241000894007 species Species 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
239000012588 trypsin Substances 0.000 description 3
FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
101150061927 BMP2 gene Proteins 0.000 description 2
102000012422 Collagen Type I Human genes 0.000 description 2
108010022452 Collagen Type I Proteins 0.000 description 2
230000006820 DNA synthesis Effects 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
229920002683 Glycosaminoglycan Polymers 0.000 description 2
241000282412 Homo Species 0.000 description 2
102000002265 Human Growth Hormone Human genes 0.000 description 2
108010000521 Human Growth Hormone Proteins 0.000 description 2
239000000854 Human Growth Hormone Substances 0.000 description 2
102100039064 Interleukin-3 Human genes 0.000 description 2
108010002386 Interleukin-3 Proteins 0.000 description 2
206010023215 Joint effusion Diseases 0.000 description 2
HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
206010061363 Skeletal injury Diseases 0.000 description 2
208000008312 Tooth Loss Diseases 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
108060008539 Transglutaminase Proteins 0.000 description 2
102100040247 Tumor necrosis factor Human genes 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
239000002250 absorbent Substances 0.000 description 2
230000002745 absorbent Effects 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
230000033115 angiogenesis Effects 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000001740 anti-invasion Effects 0.000 description 2
210000002469 basement membrane Anatomy 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
159000000007 calcium salts Chemical class 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000002131 composite material Substances 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
239000004053 dental implant Substances 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000003511 endothelial effect Effects 0.000 description 2
NGGMYCMLYOUNGM-CSDLUJIJSA-N fumagillin Chemical compound C([C@H]([C@H]([C@@H]1[C@]2(C)[C@H](O2)CC=C(C)C)OC)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)C[C@@]21CO2 NGGMYCMLYOUNGM-CSDLUJIJSA-N 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000010562 histological examination Methods 0.000 description 2
238000002513 implantation Methods 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
238000005462 in vivo assay Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000008407 joint function Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000009681 mesenchymal cell proliferation Effects 0.000 description 2
239000003475 metalloproteinase inhibitor Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
230000008520 organization Effects 0.000 description 2
230000000399 orthopedic effect Effects 0.000 description 2
210000002379 periodontal ligament Anatomy 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
235000021317 phosphate Nutrition 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000002271 resection Methods 0.000 description 2
229960003471 retinol Drugs 0.000 description 2
239000011607 retinol Substances 0.000 description 2
210000000329 smooth muscle myocyte Anatomy 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
210000001258 synovial membrane Anatomy 0.000 description 2
238000012360 testing method Methods 0.000 description 2
102000003601 transglutaminase Human genes 0.000 description 2
229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
235000019731 tricalcium phosphate Nutrition 0.000 description 2
229940078499 tricalcium phosphate Drugs 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
NGGMYCMLYOUNGM-UHFFFAOYSA-N (-)-fumagillin Natural products O1C(CC=C(C)C)C1(C)C1C(OC)C(OC(=O)C=CC=CC=CC=CC(O)=O)CCC21CO2 NGGMYCMLYOUNGM-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
102100022987 Angiogenin Human genes 0.000 description 1
102400000068 Angiostatin Human genes 0.000 description 1
108010079709 Angiostatins Proteins 0.000 description 1
241000969130 Atthis Species 0.000 description 1
108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 1
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
206010007710 Cartilage injury Diseases 0.000 description 1
102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
108090000056 Complement factor B Proteins 0.000 description 1
102000003712 Complement factor B Human genes 0.000 description 1
208000032170 Congenital Abnormalities Diseases 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
108010019393 Fibrin Foam Proteins 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
208000005422 Foreign-Body reaction Diseases 0.000 description 1
229930194076 Germanin Natural products 0.000 description 1
108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000001974 Hyaluronidases Human genes 0.000 description 1
101150088952 IGF1 gene Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000024556 Mendelian disease Diseases 0.000 description 1
MSHZHSPISPJWHW-PVDLLORBSA-N O-(chloroacetylcarbamoyl)fumagillol Chemical compound C([C@H]([C@H]([C@@H]1[C@]2(C)[C@H](O2)CC=C(C)C)OC)OC(=O)NC(=O)CCl)C[C@@]21CO2 MSHZHSPISPJWHW-PVDLLORBSA-N 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
208000002607 Pseudarthrosis Diseases 0.000 description 1
102000013275 Somatomedins Human genes 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
102100029469 WD repeat and HMG-box DNA-binding protein 1 Human genes 0.000 description 1
101710097421 WD repeat and HMG-box DNA-binding protein 1 Proteins 0.000 description 1
101000998548 Yersinia ruckeri Alkaline proteinase inhibitor Proteins 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
239000002269 analeptic agent Substances 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229940121369 angiogenesis inhibitor Drugs 0.000 description 1
108010072788 angiogenin Proteins 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
230000003527 anti-angiogenesis Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000001733 anti-osteogenic effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
208000037873 arthrodesis Diseases 0.000 description 1
FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
229960002319 barbital Drugs 0.000 description 1
239000011324 bead Substances 0.000 description 1
HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
229960000182 blood factors Drugs 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
229940112869 bone morphogenetic protein Drugs 0.000 description 1
239000000872 buffer Substances 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000011712 cell development Effects 0.000 description 1
239000005482 chemotactic factor Substances 0.000 description 1
239000003042 chondroprotective agent Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000012085 chronic inflammatory response Effects 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000000515 collagen sponge Substances 0.000 description 1
229940089482 combination collagen Drugs 0.000 description 1
230000002301 combined effect Effects 0.000 description 1
230000009514 concussion Effects 0.000 description 1
210000001608 connective tissue cell Anatomy 0.000 description 1
238000001816 cooling Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
210000000399 corneal endothelial cell Anatomy 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000005553 drilling Methods 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000035194 endochondral ossification Effects 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
230000008556 epithelial cell proliferation Effects 0.000 description 1
230000009786 epithelial differentiation Effects 0.000 description 1
230000008472 epithelial growth Effects 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
210000000968 fibrocartilage Anatomy 0.000 description 1
239000005338 frosted glass Substances 0.000 description 1
229960000936 fumagillin Drugs 0.000 description 1
230000006870 function Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
230000002607 hemopoietic effect Effects 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
235000010299 hexamethylene tetramine Nutrition 0.000 description 1
239000004312 hexamethylene tetramine Substances 0.000 description 1
VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940076264 interleukin-3 Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
210000000281 joint capsule Anatomy 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
210000004324 lymphatic system Anatomy 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000005499 meniscus Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
230000000921 morphogenic effect Effects 0.000 description 1
210000003098 myoblast Anatomy 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229940037201 oris Drugs 0.000 description 1
229910000489 osmium tetroxide Inorganic materials 0.000 description 1
239000012285 osmium tetroxide Substances 0.000 description 1
238000010883 osseointegration Methods 0.000 description 1
210000002997 osteoclast Anatomy 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
210000004786 perivascular cell Anatomy 0.000 description 1
238000013310 pig model Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000011555 rabbit model Methods 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
230000008458 response to injury Effects 0.000 description 1
238000007790 scraping Methods 0.000 description 1
210000001044 sensory neuron Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
IHQKEDIOMGYHEB-UHFFFAOYSA-M sodium dimethylarsinate Chemical compound [Na+].C[As](C)([O-])=O IHQKEDIOMGYHEB-UHFFFAOYSA-M 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
208000035736 spondylodysplastic type Ehlers-Danlos syndrome Diseases 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
108091007196 stromelysin Proteins 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
210000002437 synoviocyte Anatomy 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000006032 tissue transformation Effects 0.000 description 1
238000003325 tomography Methods 0.000 description 1
238000011541 total hip replacement Methods 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229960001322 trypsin Drugs 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
230000007998 vessel formation Effects 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Surgery (AREA)
Zoology (AREA)
Dermatology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Materials Engineering (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL12755097A 1996-06-28 1997-06-24 Methods and preparations for treating and repairing defects or wounds in cartilage or bone using a functional barrier IL127550A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/672,618 US5853746A (en)	1991-01-31	1996-06-28	Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
PCT/US1997/011208 WO1998000183A2 (en)	1996-06-28	1997-06-24	Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier

Publications (2)

Publication Number	Publication Date
IL127550A0 IL127550A0 (en)	1999-10-28
IL127550A true IL127550A (en)	2004-06-01

Family

ID=24699317

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12755097A IL127550A (en)	1996-06-28	1997-06-24	Methods and preparations for treating and repairing defects or wounds in cartilage or bone using a functional barrier

Country Status (15)

Country	Link
US (1)	US5853746A (2)
EP (1)	EP0912204B1 (2)
JP (1)	JP2000513721A (2)
KR (1)	KR20000022182A (2)
CN (1)	CN1321681C (2)
AT (1)	ATE327781T1 (2)
AU (1)	AU731172B2 (2)
BR (1)	BR9710088A (2)
DE (1)	DE69735998T2 (2)
ES (1)	ES2267145T3 (2)
IL (1)	IL127550A (2)
NO (1)	NO320089B1 (2)
NZ (1)	NZ333452A (2)
WO (1)	WO1998000183A2 (2)
ZA (1)	ZA975711B (2)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020173806A1 (en) *	1996-08-30	2002-11-21	Verigen Transplantation Service International (Vtsi) Ag	Method for autologous transplantation
US6569172B2 (en) *	1996-08-30	2003-05-27	Verigen Transplantation Service International (Vtsi)	Method, instruments, and kit for autologous transplantation
US5989269A (en)	1996-08-30	1999-11-23	Vts Holdings L.L.C.	Method, instruments and kit for autologous transplantation
US8545569B2 (en)	2001-05-25	2013-10-01	Conformis, Inc.	Patient selectable knee arthroplasty devices
US8556983B2 (en)	2001-05-25	2013-10-15	Conformis, Inc.	Patient-adapted and improved orthopedic implants, designs and related tools
US9603711B2 (en)	2001-05-25	2017-03-28	Conformis, Inc.	Patient-adapted and improved articular implants, designs and related guide tools
US8480754B2 (en)	2001-05-25	2013-07-09	Conformis, Inc.	Patient-adapted and improved articular implants, designs and related guide tools
US8882847B2 (en)	2001-05-25	2014-11-11	Conformis, Inc.	Patient selectable knee joint arthroplasty devices
US7468075B2 (en)	2001-05-25	2008-12-23	Conformis, Inc.	Methods and compositions for articular repair
US7618451B2 (en)	2001-05-25	2009-11-17	Conformis, Inc.	Patient selectable joint arthroplasty devices and surgical tools facilitating increased accuracy, speed and simplicity in performing total and partial joint arthroplasty
US8735773B2 (en)	2007-02-14	2014-05-27	Conformis, Inc.	Implant device and method for manufacture
US8083745B2 (en)	2001-05-25	2011-12-27	Conformis, Inc.	Surgical tools for arthroplasty
US7534263B2 (en)	2001-05-25	2009-05-19	Conformis, Inc.	Surgical tools facilitating increased accuracy, speed and simplicity in performing joint arthroplasty
US8771365B2 (en)	2009-02-25	2014-07-08	Conformis, Inc.	Patient-adapted and improved orthopedic implants, designs, and related tools
EP0957943B2 (en) *	1997-02-07	2008-11-26	Stryker Corporation	Matrix-free osteogenic devices, implants and methods of use thereof
US20010016646A1 (en)	1998-03-20	2001-08-23	David C. Rueger	Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US7041641B2 (en) *	1997-03-20	2006-05-09	Stryker Corporation	Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
DE19752900A1 (de) *	1997-11-28	1999-06-02	Biotechnolog Forschung Gmbh	Knochenmatrix und/oder osteogene Zellen, deren Verwendung, therapeutische Zubereitung und Kit
US6123731A (en)	1998-02-06	2000-09-26	Osteotech, Inc.	Osteoimplant and method for its manufacture
AU3548999A (en) *	1998-04-03	1999-10-25	Chiron Corporation	Use of igfi for treating articular cartilage disorders
CN1323228A (zh) *	1998-08-14	2001-11-21	维里根国际移植服务(Vtsi)股份公司	用于软骨细胞移植的方法、器械和材料
US7184814B2 (en)	1998-09-14	2007-02-27	The Board Of Trustees Of The Leland Stanford Junior University	Assessing the condition of a joint and assessing cartilage loss
US7239908B1 (en)	1998-09-14	2007-07-03	The Board Of Trustees Of The Leland Stanford Junior University	Assessing the condition of a joint and devising treatment
ATE439806T1 (de)	1998-09-14	2009-09-15	Univ Leland Stanford Junior	Zustandsbestimmung eines gelenks und schadenvorsorge
US6727224B1 (en)	1999-02-01	2004-04-27	Genetics Institute, Llc.	Methods and compositions for healing and repair of articular cartilage
ES2525553T3 (es)	1999-03-25	2014-12-26	Metabolix, Inc.	Dispositivos y aplicaciones médicas de polímeros polihidroxialcanoato
CZ2002341A3 (cs) *	1999-07-28	2002-09-11	Interface Biotech A/S	Chrupavková membrána a její použití
US20020116063A1 (en) *	1999-08-02	2002-08-22	Bruno Giannetti	Kit for chondrocyte cell transplantation
DE19957388A1 (de) *	1999-11-24	2001-06-13	Michael Sittinger	Chondroinduktive und implantierbare Substrate zur Knorpelheilung und -protektion
AU783038B2 (en)	1999-12-15	2005-09-15	Zimmer Gmbh	Preparation for repairing cartilage defects or cartilage/bone defects in human or animal joints
US20030095993A1 (en) *	2000-01-28	2003-05-22	Hanne Bentz	Gel-infused sponges for tissue repair and augmentation
US9387094B2 (en)	2000-07-19	2016-07-12	Warsaw Orthopedic, Inc.	Osteoimplant and method of making same
AU9088801A (en)	2000-09-14	2002-03-26	Univ Leland Stanford Junior	Assessing the condition of a joint and devising treatment
WO2002023483A2 (en)	2000-09-14	2002-03-21	Leland Stanford Junior University	Technique for manipulating medical images
AU2002247044B2 (en) *	2001-01-30	2006-11-16	Orthogene, Inc.	Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
US8439926B2 (en)	2001-05-25	2013-05-14	Conformis, Inc.	Patient selectable joint arthroplasty devices and surgical tools
DE60239674D1 (de)	2001-05-25	2011-05-19	Conformis Inc	Verfahren und zusammensetzungen zur reparatur der oberfläche von gelenken
AU2002343738A1 (en) *	2001-11-15	2003-05-26	University Of Medicine And Dentistry Of New Jersey	A three-dimensional matrix for producing living tissue equivalents
US7381426B2 (en) *	2002-01-24	2008-06-03	Southwest Research Institute	Targeted delivery of bioactive factors to the systemic skeleton
US20030223965A1 (en) *	2002-03-28	2003-12-04	Song Sun Uk	Bone generation by gene therapy
US20040136968A1 (en) *	2002-09-27	2004-07-15	Verigen Ag	Autologous cells on a support matrix for tissue repair
AU2003284035A1 (en)	2002-10-07	2004-05-04	Conformis, Inc.	Minimally invasive joint implant with 3-dimensional geometry matching the articular surfaces
EP3075356B1 (en)	2002-11-07	2023-07-05	ConforMIS, Inc.	Method of selecting a meniscal implant
AU2003297583B2 (en)	2002-11-26	2010-01-14	Biocon, Ltd	Modified naturetic compounds, conjugates, and uses thereof
US7067123B2 (en)	2003-04-29	2006-06-27	Musculoskeletal Transplant Foundation	Glue for cartilage repair
US7901457B2 (en)	2003-05-16	2011-03-08	Musculoskeletal Transplant Foundation	Cartilage allograft plug
US7488348B2 (en)	2003-05-16	2009-02-10	Musculoskeletal Transplant Foundation	Cartilage allograft plug
KR20060031808A (ko)	2003-06-11	2006-04-13	오스테오테크, 인코포레이티드	뼈 임플란트 및 그의 제조 방법
US20050202067A1 (en) *	2003-10-28	2005-09-15	Gkss Forschungszentrum	Matrix structure and hybrid matrix system for inducing a neofacia, their use and method for generating a neofacia
US7824711B2 (en)	2003-12-11	2010-11-02	Isto Technologies, Inc.	Particulate cartilage system
CA2571656A1 (en) *	2004-06-23	2006-01-05	Angiotech Biomaterials Corporation	Methods and crosslinked polymer compositions for cartilage repair
US8512730B2 (en)	2004-07-12	2013-08-20	Isto Technologies, Inc.	Methods of tissue repair and compositions therefor
US7837740B2 (en)	2007-01-24	2010-11-23	Musculoskeletal Transplant Foundation	Two piece cancellous construct for cartilage repair
US20090319045A1 (en)	2004-10-12	2009-12-24	Truncale Katherine G	Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8114841B2 (en) *	2004-10-14	2012-02-14	Biomimetic Therapeutics, Inc.	Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix
US7473678B2 (en)	2004-10-14	2009-01-06	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods of use thereof
US20060111778A1 (en) *	2004-10-29	2006-05-25	Michalow Alexander E	Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway
US7270655B2 (en) *	2005-01-14	2007-09-18	Haidukewych George J	Autologous material delivery apparatus and method
US7825083B2 (en) *	2005-02-10	2010-11-02	Spine Wave, Inc.	Synovial fluid barrier
US7815926B2 (en)	2005-07-11	2010-10-19	Musculoskeletal Transplant Foundation	Implant for articular cartilage repair
JP5292533B2 (ja)	2005-08-26	2013-09-18	ジンマー・インコーポレイテッド	インプラントおよび関節疾患の治療、置換および治療方法
CA2623106C (en)	2005-09-19	2013-12-24	Histogenics Corporation	Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP2649951A3 (en)	2006-02-06	2013-12-25	ConforMIS, Inc.	Patient selectable joint arthroplasty devices and surgical tools
US8623026B2 (en)	2006-02-06	2014-01-07	Conformis, Inc.	Patient selectable joint arthroplasty devices and surgical tools incorporating anatomical relief
ES2427993T3 (es) *	2006-02-09	2013-11-05	Biomimetic Therapeutics, Llc	Composiciones y métodos para el tratamiento de hueso
US9161967B2 (en)	2006-06-30	2015-10-20	Biomimetic Therapeutics, Llc	Compositions and methods for treating the vertebral column
CA2656278C (en)	2006-06-30	2016-02-09	Biomimetic Therapeutics, Inc.	Compositions and methods for treating rotator cuff injuries
US8106008B2 (en)	2006-11-03	2012-01-31	Biomimetic Therapeutics, Inc.	Compositions and methods for arthrodetic procedures
US8163549B2 (en)	2006-12-20	2012-04-24	Zimmer Orthobiologics, Inc.	Method of obtaining viable small tissue particles and use for tissue repair
US8870871B2 (en) *	2007-01-17	2014-10-28	University Of Massachusetts Lowell	Biodegradable bone plates and bonding systems
ES2542509T3 (es) *	2007-01-22	2015-08-06	Orthotrophix, Inc.	Una composición peptídica y un método de estimulación de la formación de cartílago
WO2008101090A2 (en)	2007-02-14	2008-08-21	Conformis, Inc.	Implant device and method for manufacture
US8435551B2 (en)	2007-03-06	2013-05-07	Musculoskeletal Transplant Foundation	Cancellous construct with support ring for repair of osteochondral defects
AU2008240191B2 (en)	2007-04-12	2013-09-19	Zimmer, Inc.	Compositions and methods for tissue repair
WO2008157412A2 (en)	2007-06-13	2008-12-24	Conformis, Inc.	Surgical cutting guide
EP2259807B1 (en)	2008-02-07	2013-04-24	Biomimetic Therapeutics, Inc.	Compositions for distraction osteogenesis
US8682052B2 (en)	2008-03-05	2014-03-25	Conformis, Inc.	Implants for altering wear patterns of articular surfaces
AU2009246474B2 (en)	2008-05-12	2015-04-16	Conformis, Inc.	Devices and methods for treatment of facet and other joints
KR20110067035A (ko)	2008-09-09	2011-06-20	바이오미메틱 세라퓨틱스, 인크.	건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
US8808297B2 (en)	2009-02-24	2014-08-19	Microport Orthopedics Holdings Inc.	Orthopedic surgical guide
EP2405865B1 (en)	2009-02-24	2019-04-17	ConforMIS, Inc.	Automated systems for manufacturing patient-specific orthopedic implants and instrumentation
US8808303B2 (en)	2009-02-24	2014-08-19	Microport Orthopedics Holdings Inc.	Orthopedic surgical guide
US12383287B2 (en)	2009-02-24	2025-08-12	Microport Orthopedics Holdings, Inc.	Systems and methods for installing an orthopedic implant
US9017334B2 (en)	2009-02-24	2015-04-28	Microport Orthopedics Holdings Inc.	Patient specific surgical guide locator and mount
SG175229A1 (en)	2009-04-16	2011-11-28	Conformis Inc	Patient-specific joint arthroplasty devices for ligament repair
AU2010327987B2 (en)	2009-12-11	2015-04-02	Conformis, Inc.	Patient-specific and patient-engineered orthopedic implants
CN102811622A (zh)	2010-02-22	2012-12-05	生物模拟治疗公司	用于治疗腱病的血小板衍生生长因子组合物和方法
US8435305B2 (en)	2010-08-31	2013-05-07	Zimmer, Inc.	Osteochondral graft delivery device and uses thereof
US9717779B2 (en) *	2011-01-31	2017-08-01	Warsaw Orthopedic, Inc.	Implantable matrix having optimum ligand concentrations
SG193484A1 (en)	2011-02-15	2013-10-30	Conformis Inc	Patent-adapted and improved articular implants, designs, surgical procedures and related guide tools
US9486226B2 (en)	2012-04-18	2016-11-08	Conformis, Inc.	Tibial guides, tools, and techniques for resecting the tibial plateau
US9675471B2 (en)	2012-06-11	2017-06-13	Conformis, Inc.	Devices, techniques and methods for assessing joint spacing, balancing soft tissues and obtaining desired kinematics for joint implant components
US20140017292A1 (en)	2012-07-11	2014-01-16	Osiris Therapeutics, Inc.	Methods of manufacturing cartilage products
US10245306B2 (en)	2012-11-16	2019-04-02	Isto Technologies Ii, Llc	Flexible tissue matrix and methods for joint repair
US20140178343A1 (en)	2012-12-21	2014-06-26	Jian Q. Yao	Supports and methods for promoting integration of cartilage tissue explants
US10179191B2 (en)	2014-10-09	2019-01-15	Isto Technologies Ii, Llc	Flexible tissue matrix and methods for joint repair
US10077420B2 (en)	2014-12-02	2018-09-18	Histogenics Corporation	Cell and tissue culture container
US11083755B2 (en) *	2015-01-08	2021-08-10	The Board Of Trustees Of The Leland Stanford Junior University	Factors and cells that provide for induction of bone, bone marrow, and cartilage
AU2020283377B2 (en)	2019-05-29	2022-08-04	Wright Medical Technology, Inc.	Preparing a tibia for receiving tibial implant component of a replacement ankle
US12396739B2 (en)	2020-01-17	2025-08-26	Wright Medical Technology, Inc.	Guidance tools, systems, and methods
US12440227B2 (en)	2021-02-24	2025-10-14	Wright Medical Technology, Inc.	Preparing a tibia for receiving tibial implant component of a replacement ankle
US12582421B2 (en)	2022-05-13	2026-03-24	Wright Medical Technology, Inc.	Intraoperative adjustable guides, systems, and methods
CN114984298A (zh) *	2022-07-18	2022-09-02	重庆大学	一类软骨组织粘合剂及其制备方法和用途
US12569355B2 (en)	2023-08-31	2026-03-10	Wright Medical Technology, Inc.	Systems and methods for total ankle arthroplasty

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4994443A (en) *	1982-12-20	1991-02-19	The Children's Medical Center Corporation	Inhibition of angiogenesis
US5001116A (en) *	1982-12-20	1991-03-19	The Children's Medical Center Corporation	Inhibition of angiogenesis
IL68218A (en) *	1983-03-23	1985-12-31	Univ Ramot	Compositions for cartilage repair comprising embryonal chondrocytes
US4609551A (en) *	1984-03-20	1986-09-02	Arnold Caplan	Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites
US4563350A (en) *	1984-10-24	1986-01-07	Collagen Corporation	Inductive collagen based bone repair preparations
AU590872B2 (en) *	1985-02-26	1989-11-23	Johns Hopkins University, The	Neovascularization inhibitors and methods for their production and use
US5041138A (en) *	1986-11-20	1991-08-20	Massachusetts Institute Of Technology	Neomorphogenesis of cartilage in vivo from cell culture
US4846835A (en) *	1987-06-15	1989-07-11	Grande Daniel A	Technique for healing lesions in cartilage
US5306311A (en) *	1987-07-20	1994-04-26	Regen Corporation	Prosthetic articular cartilage
US4904259A (en) *	1988-04-29	1990-02-27	Samuel Itay	Compositions and methods for repair of cartilage and bone
US4950483A (en) *	1988-06-30	1990-08-21	Collagen Corporation	Collagen wound healing matrices and process for their production
US5236456A (en) *	1989-11-09	1993-08-17	Osteotech, Inc.	Osteogenic composition and implant containing same
EP0512071B1 (en) *	1990-01-25	1996-10-30	Children's Hospital	Method and compositions for inhibiting angiogenesis
DE4006609A1 (de) *	1990-03-02	1991-09-26	Max Planck Gesellschaft	Inhibitor der proliferation von endothelzellen
US5268384A (en) *	1990-11-21	1993-12-07	Galardy Richard E	Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
WO1992010210A1 (en) *	1990-12-14	1992-06-25	E.I. Du Pont De Nemours And Company	Inhibition of angiogenesis by il-1
US5206023A (en) *	1991-01-31	1993-04-27	Robert F. Shaw	Method and compositions for the treatment and repair of defects or lesions in cartilage
US5270300A (en) *	1991-09-06	1993-12-14	Robert Francis Shaw	Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5382514A (en) *	1992-03-31	1995-01-17	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	In vivo angiogenesis assay
US5368051A (en) *	1993-06-30	1994-11-29	Dunn; Allan R.	Method of regenerating articular cartilage
EP1155689B1 (en) *	1993-07-19	2006-09-20	Angiotech Pharmaceuticals, Inc.	Anti-angiogenic stents and methods of their preparation
EP0637450A3 (en) *	1993-08-04	1995-04-05	Collagen Corp	Method and composition for resuscitation of hereditary tissue.
CA2176934A1 (en) *	1993-11-17	1995-05-26	Ramnath Sasisekharan	Method for inhibiting angiogenesis using heparinase
DE69530914T2 (de) *	1994-02-17	2004-03-11	New York Blood Center, Inc.	Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung

1996
- 1996-06-28 US US08/672,618 patent/US5853746A/en not_active Expired - Lifetime
1997
- 1997-06-24 DE DE69735998T patent/DE69735998T2/de not_active Expired - Fee Related
- 1997-06-24 KR KR1019980710600A patent/KR20000022182A/ko not_active Withdrawn
- 1997-06-24 BR BR9710088A patent/BR9710088A/pt not_active Application Discontinuation
- 1997-06-24 AT AT97932329T patent/ATE327781T1/de not_active IP Right Cessation
- 1997-06-24 WO PCT/US1997/011208 patent/WO1998000183A2/en not_active Ceased
- 1997-06-24 AU AU35815/97A patent/AU731172B2/en not_active Ceased
- 1997-06-24 JP JP10504318A patent/JP2000513721A/ja not_active Ceased
- 1997-06-24 ES ES97932329T patent/ES2267145T3/es not_active Expired - Lifetime
- 1997-06-24 NZ NZ333452A patent/NZ333452A/xx unknown
- 1997-06-24 EP EP97932329A patent/EP0912204B1/en not_active Expired - Lifetime
- 1997-06-24 CN CNB97196887XA patent/CN1321681C/zh not_active Expired - Fee Related
- 1997-06-24 IL IL12755097A patent/IL127550A/en not_active IP Right Cessation
- 1997-06-26 ZA ZA9705711A patent/ZA975711B/xx unknown
1998
- 1998-12-23 NO NO19986083A patent/NO320089B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69735998T2 (de)	2007-03-15
DE69735998D1 (de)	2006-07-06
NO320089B1 (no)	2005-10-24
AU3581597A (en)	1998-01-21
WO1998000183A3 (en)	1998-02-12
EP0912204A2 (en)	1999-05-06
US5853746A (en)	1998-12-29
ATE327781T1 (de)	2006-06-15
AU731172B2 (en)	2001-03-22
EP0912204B1 (en)	2006-05-31
NZ333452A (en)	2000-04-28
HK1017276A1 (en)	1999-11-19
NO986083D0 (no)	1998-12-23
ES2267145T3 (es)	2007-03-01
JP2000513721A (ja)	2000-10-17
BR9710088A (pt)	1999-08-10
CN1321681C (zh)	2007-06-20
IL127550A0 (en)	1999-10-28
KR20000022182A (ko)	2000-04-25
ZA975711B (en)	1998-01-26
WO1998000183A2 (en)	1998-01-08
CN1226839A (zh)	1999-08-25
NO986083L (no)	1999-03-01

Legal Events

Date	Code	Title	Description
2004-11-10	FF	Patent granted
2005-09-25	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
US5853746A (en)	1998-12-29	Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
EP0530804B1 (en)	2004-06-02	Kits and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5206023A (en)	1993-04-27	Method and compositions for the treatment and repair of defects or lesions in cartilage
AU2002247044B2 (en)	2006-11-16	Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
CA2258601C (en)	2007-04-10	Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
HK1017276B (en)	2007-01-19	Compositions for the treatment and repair of defects in cartilage using functional barrier
TW505518B (en)	2002-10-11	Compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
HK1012587B (en)	2005-02-18	Kits and compositions for the treatment and repair of defects or lesions in cartilage or bone
HK1006416B (en)	1999-02-26	Growth factor containing matrix for the treatment of cartilage lesions